Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial
K ZamanInternational Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, BangladeshDang Duc AnhNational Institute of Hygiene and Epidemiology, Ministry of Health, Hanoi, VietnamJohn C. VictorPATH, Seattle, WA, USASunheang ShinInternational Vaccine Institute, Seoul, KoreaMd YunusInternational Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, BangladeshMichael J. DallasMerck Research Laboratories, North Wales, PA, USAGoutam PodderInternational Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, BangladeshVu Dinh ThiemNational Institute of Hygiene and Epidemiology, Ministry of Health, Hanoi, VietnamLe Thi Phuong MaiNational Institute of Hygiene and Epidemiology, Ministry of Health, Hanoi, VietnamStephen P LubyInternational Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, BangladeshLe Huu ThoKhanh Hoa Health Service, Nha Trang, VietnamMichele L. CoiaMerck Research Laboratories, North Wales, PA, USAKristen LewisPATH, Seattle, WA, USAStephen B. RiversMerck Research Laboratories, North Wales, PA, USADavid A SackBloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USAF. SchödelMerck Research Laboratories, North Wales, PA, USAA. Duncan SteeleInitiative for Vaccine Research, WHO, Geneva, SwitzerlandKathleen M. NeuzilPATH, Seattle, WA, USAMax CiarletMerck Research Laboratories, North Wales, PA, USA
2010en
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
2 ta iqtibos0 ta foydalanilgan manba